This interactive symposium will explore the diagnosis, treatment, and management of respiratory failure and pneumonia in critically ill patients, focusing on the gaps and unmet needs of current standards of care, the promise of emerging therapies for ventilator-associated pneumonia, and how practical strategies for antimicrobial and diagnostic stewardship can help preserve available antibiotics for multidrug resistant gram-negative organisms and improve patient outcomes.

Marin H. Kollef, MD

Professor of Medicine, Virginia E. and Sam J. Golman Chair in Respiratory Intensive Care Medicine, Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, Director, Critical Care Research, Director, Respiratory Care Services, Barnes-Jewish Hospital, St. Louis, Missouri, United States

Lee E. Morrow, MD, MSc

Professor of Medicine, Creighton University, Omaha, Nebraska, United States

Andrew F. Shorr, MD, MPH

Director, Pulmonary and Critical Care Medicine, Medstar Washington Hospital Center, Washington, DC, United States

Richard G. Wunderink, MD

Professor of Medicine, Northwestern Medicine, Feinberg School of Medicine, Chicago, IL, United States

Date

Tuesday, October 31 @ 5:30 AM

5:30am - 6:00am

Breakfast & Registration

6:00am - 7:00am

Presentation

Welcome and Introductions

Marin H. Kollef, MD

Respiratory Failure and Ventilator-Associated Pneumonia: A Critical Problem for Critical Care

Andrew F. Shorr, MD

Treating Gram-Negative Pneumonia Today: Challenges and Considerations

Lee E. Morrow, MD

NEW DATA ON AEROSOLIZED ANTIBIOTICS: WHY SHOULD WE USE THEM?

Marin H. Kollef, MD

Antimicrobial Stewardship

Richard G. Wunderink, MD

Closing Remarks

Marin H. Kollef, MD

Question & Answer

Target Audience

This activity is intended for intensivists, pulmonologists, infectious disease specialists, and hospitalists.

Goal Statement

The goal of this activity is to improve clinical practices for the diagnosis, treatment, and management of gram-negative pneumonia in critically ill patients.

Learning Objectives

Upon completion of this activity, participants will have:

• Increased knowledge regarding the
  • Current treatment strategies for gram-negative pneumonia
  • Burden of ventilator-associated pneumonia
  • Emerging data on device-delivered antimicrobial therapy for patients with ventilator-associated pneumonia

• Greater competence related to
  • Antimicrobial stewardship strategies for gram-negative pneumonia

Accreditation Statement

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credits Available:
Maximum Of 1.0 AMA PRA Category 1 Credit(s)™

Medscape, LLC designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

DISCLAIMER

This symposium is not sponsored, endorsed, or accredited by the American College of Chest Physicians.

Sheraton Centre Hotel

Grand Centre Ballroom

123 Queen St W, Toronto, ON M5H 3M9, Canada

Supported by an independent educational grant from: